Evidence map›Paper›PMID 34430812›Full record

ArticleiScience2021

Bacterial surface properties influence the activity of the TAT-RasGAP

Maria Georgieva, Tytti Heinonen, Alessandra Vitale, Simone Hargraves, Senka Causevic, Trestan Pillonel, Leo Eberl, Christian Widmann, Nicolas Jacquier

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria GeorgievaDepartment of Biomedical Sciences, University of Lausanne, Lausanne 1005, Switzerland.
Tytti HeinonenInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.
Alessandra VitaleDepartment of Plant and Microbial Biology, University of Zurich, Zurich 8008, Switzerland.
Simone HargravesInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.
Senka CausevicInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.
Trestan PillonelInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.
Leo EberlDepartment of Plant and Microbial Biology, University of Zurich, Zurich 8008, Switzerland.
Christian WidmannDepartment of Biomedical Sciences, University of Lausanne, Lausanne 1005, Switzerland.
Nicolas JacquierInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is an increasing threat for public health, underscoring the need for new antibacterial agents. Antimicrobial peptides (AMPs) represent an alternative to classical antibiotics. TAT-RasGAP

Indexed as

BiochemistryMicrobiologyPeptides

Identifiers

PMID34430812
PMCPMC8365389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.